ACTA1 and fibrosis: Consistent with the development of hepatic fibrosis, α‐SMA immunohistochemistry staining revealed increased expression of α‐SMA in liver tissue of the B6 HFD mice; however, the increase was significantly reduced with L6H21 treatment or MD2 knockout (Fig. 2G and H).